Paul Y. Song - 04 Dec 2023 Form 4 Insider Report for NKGen Biotech, Inc. (NKGN)

Role
Chief Executive Officer, Director
Signature
/s/ Paul Y. Song, M.D.
Issuer symbol
NKGN
Transactions as of
04 Dec 2023
Net transactions value
+$850
Form type
4
Filing time
05 Dec 2023, 15:51:22 UTC
Previous filing
28 Nov 2023
Next filing
07 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKGN Common Stock Purchase $500 +163 +0.1% $3.07 170,864 04 Dec 2023 Direct
transaction NKGN Common Stock Purchase $350 +105 +0.06% $3.33 170,969 05 Dec 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.